Second COVID wave humanitarian crisis, not economic; likely to have peaked: Report

Nomura said it expects the overall hit to sequential growth in April-June to be much less severe than last year when there was a complete nationwide lockdown, and less than what the drop in mobility suggests. It estimated the economy to contract by only 3.8 per cent in June quarter as compared with March quarter.

PTI
May 20, 2021 / 02:33 PM IST

Representative Image

The second wave of the pandemic in India is more of a humanitarian crisis rather than an economic one, and is likely to have peaked, a Japanese brokerage said on Thursday.

Nomura said it expects the overall hit to sequential growth in April-June to be much less severe than last year when there was a complete nationwide lockdown, and less than what the drop in mobility suggests. It estimated the economy to contract by only 3.8 per cent in June quarter as compared with March quarter.

“..lockdowns are more nuanced this time and consumers and businesses have adapted,” it said, adding that international experience also suggests the same.

Highlighting that the improving global growth will act as a tailwind, the brokerage said it expects the current lockdowns to last six more weeks.

The brokerage said vaccinations are “trailing” at present, but the pace of inoculation will pick up after June as its analysis indicates increased supply.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“We expect half of the population to be fully vaccinated by end-2021 and India to reach its vaccine pivot point in Q3 (September quarter), which should boost domestic consumption,” it added.

Maintaining its 10.8 per cent GDP growth estimate for 2021-22, Nomura said the full impact of easy financial conditions should become visible as the pandemic''s uncertainty ebbs and vaccinations rise.

However, in what can be a potential area of concern, the brokerage said it expects cost pressures to intensify from supply chain disruptions, high global commodity prices and rising rural wages, and the core inflation remaining at an elevated 5.3 per cent for 2021.

“We expect a reverse repo rate hike in October and maintain our call for 0.50 per cent of repo rate hikes in H12022,” it said.
PTI
TAGS: #coronavirus #Covid-19 #Current Affairs #inda #vaccine
first published: May 20, 2021 02:34 pm